US FDA Committee to Review AstraZeneca’s Imfinzi t...
Category : Clinical Trial Update 27 July 2024US FDA Committee to review AstraZeneca’s Imfinzi to treat resectable NSCLC based on AEGEAN pha...
News
Merus Begins Patient Dosing in LiGeR-HN2, a Phase...
Category : Clinical Trial Update 27 July 2024Overview Merus N.V., a clinical-stage oncology company developing innovative, full-length multisp...
Ractigen Secures FDA Rare Pediatric Disease Design...
Category : Approval/Launch 27 July 2024Ractigen Secures FDA Rare Pediatric Disease Designation for RAG-18 in Duchenne Muscular Dystrophy Tr...
Bio-Thera Solutions Initiates Integrated Phase I /...
Category : Clinical Trial Update 27 July 2024Bio-Thera Solutions Initiates Integrated Phase I / Phase III Clinical Trial for BAT3306, a Proposed...
UK MHRA Approves Pfizer/BioNTech’s Comirnaty JN.1...
Category : Approval/Launch 26 July 2024UK MHRA approves Pfizer/BioNTech’s Comirnaty JN.1 Covid-19 vaccine for adults and children fro...
Latest Newsletter Post
-
Bio-Thera Solutions Initiates Integ..
27 July 2024
-
Ractigen Secures FDA Rare Pediatric..
27 July 2024
-
Merus Begins Patient Dosing in LiGe..
27 July 2024
-
US FDA Committee to Review AstraZen..
27 July 2024
-
US FDA Approves LEQSELVI™ (Deuruxol..
26 July 2024
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-335
Mobile: +91-9990237670
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com